Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Relation Between Safety Endpoints and Everolimus Trough Blood Level in Advanced Renal Cell Carcinoma

NCT01598038 is registered in ClinicalTrials.gov with Centre Francois Baclesse as lead sponsor.

NCT NCT01598038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01598038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Relation Between Safety Endpoints and Everolimus Trough Blood Level in Advanced Renal Cell Carcinoma
Lead sponsor
Centre Francois Baclesse
Phase
Not applicable
Overall status
Terminated
Start date
April 30, 2012
Completion date
December 31, 2015
Enrollment
41 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

renal cell carcinoma